CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Other acquisition Chief Executive Officer acquired 1,000,000 shares (other)
- 4 Open-market buy Chief Executive Officer bought 15,695 shares at an average $0.17 ($2,636)
- 4 Open-market buy Chief Executive Officer bought 51,701 shares at an average $0.18 ($9,230)
- 4 Open-market buy Chief Executive Officer bought 30,000 shares at an average $0.20 ($5,883)
- 4 Open-market buy Chief Executive Officer bought 42,500 shares at an average $0.18 ($7,625)
- 4 Open-market buy Chief Executive Officer bought 50,606 shares at an average $0.16 ($8,304)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at an average $0.27 ($2,653)
- 4 Other acquisition Director acquired 40,800 shares (code O)
- 4 Open-market buy Chief Executive Officer bought 34,000 shares at $0.29 ($9,799)
- 4 Open-market buy Chief Executive Officer bought 105,000 shares at an average $0.22 ($23,472)
- 3 Insider Initial Statement of Ownership
- 4/A Grant or award Chief Executive Officer acquired 212,500 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 212,500 shares at $0.26 ($55,250)
- 4 Open-market sale 10% owner sold 800,000 shares at $0.23 ($184,000)
- 4 Open-market buy President, Immudyne PR bought 600,000 shares at $0.23 ($138,000)
- 4 Open-market buy President, Immudyne PR bought 25,133 shares at $0.39 ($9,802)
- 4 Open-market buy President, Immudyne PR bought 24,867 shares at $0.39 ($9,698)
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
Page 11 of 12 · 230 filings